Marinus Pharmaceuticals, Inc. announced it raised $1.23 Million in an initial filing from an offering of $1.23 Million

Apr 04, 2022•almost 4 years ago

Amount Raised

$1.23 Million

Round Type

seed

RadnorHealthcare

Company Information

Company

MARINUS PHARMACEUTICALS, INC.

Location

5 Radnor Corporate Center, Suite 500

Radnor, Pennsylvania, United States

About

Marinus Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to the development of ganaxolone, offering a new mechanism of action with demonstrated safety and convenient dosing for patients affected by epilepsy and CNS disorders.

Related People

12 contacts

Marinus Pharmaceuticals, Inc. announced it raised $1.23 Million in an initial filing from an offering of $1.23 Million

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Company Information